Christopher Henney
2010
In 2010, Christopher Henney earned a total compensation of $30K as Acting principal executive officer; Chairman of the Board of Directors at Oncothyreon, a 47% decrease compared to previous year.
Compensation breakdown
| Stock Awards | $30,000 |
|---|---|
| Total | $30,000 |
Henney received $30K in stock awards, accounting for 100% of the total pay in 2010.
Rankings
In 2010, Christopher Henney's compensation ranked 10,386th out of 10,439 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,386 out of 10,439 | 1st |
Division Services | 1,521 out of 1,533 | 1st |
Major group Engineering, Accounting, Research, Management, And Related Services | 166 out of 166 | 0th |
Industry group Research, Development, And Testing Services | 46 out of 46 | 0th |
Industry Commercial Physical and Biological Research | 43 out of 43 | 0th |
Source: SEC filing on April 24, 2012.
Henney's colleagues
We found six more compensation records of executives who worked with Christopher Henney at Oncothyreon in 2010.
2010
Robert Kirkman
Oncothyreon
Chief Executive Officer
2010
Diana Hausman
Oncothyreon
Chief Medical Officer
2010
Gary Christianson
Oncothyreon
Chief Operating Officer
2010
Scott Peterson
Oncothyreon
Chief Scientific Officer
2010
Julia Eastland
Oncothyreon
Chief Financial Officer
2010
Shashi Karan
Oncothyreon